ALSO READCCI to probe pharma, health care sectors Sun Pharmaceutical, Dr Reddy's line up new drugs amid price war Take a call on banned combination medicines: SC to drugs advisory board Merck may sell consumer health business to focus on new drugs Differential pricing: How stent makers want patients, doctors to benefit
The National Pharmaceutical Pricing Authority (NPPA), in an investigation of treatment costs at private hospitals, has found these hospitals are making a profit of up to 1,700 per cent on drugs and consumables. For items like normal saline, the margin is 316 per cent.
An oxygen mask procured for Rs 26.41 has a maximum retail price of Rs 230. The margin on this is 771 per cent.
The drug price controller also states hospitals and doctors are violating the system by prescribing fixed dose combinations and new drugs which are not under price control.
The analysis, released on Tuesday, focused on how charges levied on diagnostics were much higher than those at independently-run diagnostics centres.
On disposables like syringes, the probe revealed that patients were not allowed to purchase these from outlets outside the hospital at discounted prices.
The expenditure on drugs and devices is 46 per cent and this expenditure is over and above the package cost in the case of implants.
The investigation was conducted by NPPA after patients complained of overcharging. The order issued by the drug price regulator said that consumers complained that the bill was thrice the estimated price.
Surgery cost is found to be only 0.39 per cent of the total.
Cost of other procedures is 11.42 per cent of total treatment cost.